Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by MelnykWasRighton Jan 21, 2022 3:48pm
129 Views
Post# 34344464

RE:RE:RE:Snapshot of "product pipeline" from Acerus website!

RE:RE:RE:Snapshot of "product pipeline" from Acerus website!Tom you are the only one posing here.  The sole purpose of your banter is to distract from what professionals can only say is a pitiful excuse for a pharma startup.  A startup 11 years in the making and at 3 cents a share and zero volume.

That sir is reality.  Face it.  Products in the pipeline? They aren't even selling Natesto in Canada.  How can you expect them to sell anything else?  You don't need a professional to show you quarterly reports.  Just read them and weep.

You are being paid by Acerus and that's abundantly clear.  You are part of the problem by encouraging people to invest in company that has completely squandered a golden opportunity.

So I agree folks, get a professional opinion on Acerus and avoid the grief the remaining non-insider shareholders are experiencing.

There's nothing stopping "those people" from getting their digs in while they can.  At least they get something for their money and keep us entertained in the process.  Your shtick is worn out Tom.

MWR
<< Previous
Bullboard Posts
Next >>